Review



human genome g3 sureprint 8 × 60 k microarray  (Agilent technologies)


Bioz Verified Symbol Agilent technologies is a verified supplier
Bioz Manufacturer Symbol Agilent technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Agilent technologies human genome g3 sureprint 8 × 60 k microarray
    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities
    Human Genome G3 Sureprint 8 × 60 K Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome g3 sureprint 8 × 60 k microarray/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    human genome g3 sureprint 8 × 60 k microarray - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Copy number variant analysis for syndromic congenital heart disease in the Chinese population"

    Article Title: Copy number variant analysis for syndromic congenital heart disease in the Chinese population

    Journal: Human Genomics

    doi: 10.1186/s40246-022-00426-8

    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities
    Figure Legend Snippet: Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities

    Techniques Used: Diagnostic Assay, Mutagenesis, Microarray, Chromatin Immunoprecipitation, Multiplex Assay, Ligation, Amplification



    Similar Products

    90
    Agilent technologies human genome g3 sureprint 8 × 60 k microarray
    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities
    Human Genome G3 Sureprint 8 × 60 K Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome g3 sureprint 8 × 60 k microarray/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    human genome g3 sureprint 8 × 60 k microarray - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies sureprint g3 human genome 8 × 60 k microarray
    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities
    Sureprint G3 Human Genome 8 × 60 K Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sureprint g3 human genome 8 × 60 k microarray/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    sureprint g3 human genome 8 × 60 k microarray - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies human genome g3 sureprint 8 ∗60 k microarray
    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities
    Human Genome G3 Sureprint 8 ∗60 K Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome g3 sureprint 8 ∗60 k microarray/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    human genome g3 sureprint 8 ∗60 k microarray - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities

    Journal: Human Genomics

    Article Title: Copy number variant analysis for syndromic congenital heart disease in the Chinese population

    doi: 10.1186/s40246-022-00426-8

    Figure Lengend Snippet: Diagnostic yield of CMA in studies of syndromic CHD from different countries or ethnicities

    Article Snippet: 8 [ ] , Brazil , 2017 , 0.60–17.4 Mb , Agilent Human Genome G3 SurePrint 8 × 60 K microarray or Affymetrix CytoScan HD chip , ≥ 300 kb; relevant CNVs searched in DGV, DECIPHER, and OMIM , 8/78 (10.3%) , F (62.5%), H (25.0%), B (12.5%) , Craniofacial defects (100%), Neurodevelopmental disorders (87.5%), musculoskeletal disorders (62.5%).

    Techniques: Diagnostic Assay, Mutagenesis, Microarray, Chromatin Immunoprecipitation, Multiplex Assay, Ligation, Amplification